You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Darapladib

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Darapladib?

Darapladib is an investigational drug.

There have been 19 clinical trials for Darapladib. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2009.

The most common disease conditions in clinical trials are Atherosclerosis, Myocardial Ischemia, and Coronary Artery Disease. The leading clinical trial sponsors are GlaxoSmithKline, Mayo Clinic, and National Institute on Aging (NIA).

Recent Clinical Trials for Darapladib
Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)GlaxoSmithKlinePhase 1
Darapladib China PKGlaxoSmithKlinePhase 1
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy SubjectsGlaxoSmithKlinePhase 1

See all Darapladib clinical trials

Clinical Trial Summary for Darapladib

Top disease conditions for Darapladib
Top clinical trial sponsors for Darapladib

See all Darapladib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.